Investors & Media
  • 27 September 2023
    Selvita sums up H1 2023 and sees a positive outlook for 2024
  • 25 September 2023
    Selvita expands its cooperation with one of the largest Big Pharma companies in the area of integrated drug discovery support
  • 05 June 2023
    The University of Oxford and Selvita Collaborate to Advance Potential Therapeutics for Parkinson's Disease
  • 31 May 2023
    Selvita Q1 2023 financial results exceed initial estimates, the Company is preparing for further dynamic growth
  • 30 March 2023
    Selvita with record results in 2022, builds a base for further dynamic growth in upcoming periods
  • 28 March 2023
    Selvita Joins’s IND Package Pipeline Program
  • 27 March 2023
    Selvita continues to scale its operations with the completion of new research centre
  • 15 March 2023
    Selvita named the second-best company on the Warsaw Stock Exchange for 2022
  • 09 February 2023
    Passion for science drives discoveries. From target validation to clinical candidate selection.
  • 19 January 2023
    We are Selvita. Together we transform science into discoveries.


    Media Relations

    Investor Relations

    Download media package

    Ready to partner with us?

    Get started